Enzymatic RNA synthesis paves the way for sustainable therapeutics
Can't see this email? View it online
   
  Muscular Dystrophy Muscular Dystrophy logo  
  The latest muscular dystrophy news from News Medical  
 Breakthrough gene therapy offers hope for Duchenne muscular dystrophyBreakthrough gene therapy offers hope for Duchenne muscular dystrophy
 
A new gene therapy treatment for Duchenne muscular dystrophy shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.
 
   Enzymatic RNA synthesis paves the way for sustainable therapeuticsEnzymatic RNA synthesis paves the way for sustainable therapeutics
 
While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis.
 
   UH research identifies key mechanisms of skeletal muscle regenerationUH research identifies key mechanisms of skeletal muscle regeneration
 
Newly published research from the University of Houston College of Pharmacy identifies key mechanisms of skeletal muscle regeneration and growth of muscles following resistance exercise.
 
 New gene therapy approach improves muscle strength in DMD mice
 
New gene therapy approach improves muscle strength in DMD miceIndiana University School of Medicine researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
 
 
 Harnessing enzymes for making RNA therapeutics
 
Harnessing enzymes for making RNA therapeuticsWhile the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis.